T1	Participants 0 38	Anaerobic infection in cancer patients
T2	Participants 258 382	rates of favorable response were 89% in patients receiving clindamycine alone and 78% in patients receiving cefoxitin alone.
T3	Participants 479 569	20 of 24 patients (83%) responded to clindamycin and 18 of 22 (82%) responded to cefoxitin
